Comparison on the efficacy of Chinese-made novel-designed mechanical-locked and elastic self-locked transcatheter edge-to-edge repair system in the treatment of patients with functional mitral regurgitation / 中华心血管病杂志
Chinese Journal of Cardiology
; (12): 832-837, 2023.
Article
Dans Zh
| WPRIM
| ID: wpr-1046026
Responsable en Bibliothèque :
WPRO
ABSTRACT
Objective:
To evaluate and compare the short-term efficacy of domestic mechanical-locked (Clip2Edge) and elastic self-locked (ValveClip) transcranial mitral valve edge-to-edge interventional repair (TEER) devices in the treatment of functional mitral regurgitant valves.Methods:
In this retrospective non-randomized comparative study, patients underwent TEER procedure in Fuwai Yunnan Cardiovascular Disease Hospital from May 2022 to April 2023 for heart failure combined with moderate to severe or severe functional mitral valve were divided into Clip2Edge and ValveClip groups based on the TEER system used. Baseline, perioperative, and postoperative 30 d follow-up data were collected and compared between the two groups. The primary outcome was the success rate on the 30 d post operation, while secondary outcomes included immediate postoperative technical success rate and the incidence of all-cause mortality on the 30 d post operation, readmission rate of acute heart failure, cerebral infarction, severe bleeding, and other serious adverse events rates.Results:
A total of 60 patients were enrolled, 34 patients were in the Clip2Edge group and 26 in the ValveClip group, mean age was (63.8±9.3) years, and 24 patients (40%) were female. There were no significant differences in baseline data of age, cardiac function, comorbidities, mitral regurgitation 4+(19(73%) vs. 29(85%)), the end-diastolic volume of left ventricle ((220.8±91.2) ml vs. (210.8±71.7) ml) between the two groups (all P>0.05). The technical success rate immediately after the procedure was 100%. There were no readmission of acute heart failure, death, cerebral infarction, severe bleeding, and other serious adverse events up to the 30 d follow-up. Device success rate was similar between the ValveClip group (24 cases (100%)) and the Clip2Edge group (27 cases (96%)) (P>0.05).Conclusion:
Both types of novel domestic TEER devices are safe and feasible in treating patients with functional mitral regurgitation.
Texte intégral:
1
Indice:
WPRIM
Sujet Principal:
Cathétérisme cardiaque
/
Chine
/
Études rétrospectives
/
Résultat thérapeutique
/
Implantation de valve prothétique cardiaque
/
Peuples d'Asie de l'Est
/
Défaillance cardiaque
/
Insuffisance mitrale
Limites du sujet:
Aged
/
Female
/
Humans
/
Male
Pays comme sujet:
Asia
langue:
Zh
Texte intégral:
Chinese Journal of Cardiology
Année:
2023
Type:
Article